Company / Tangible Book Value per Share
Twist Bioscience Corp Tangible Book Value per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$6.53
FY2025
5-year range
$6.53 / $13.06
FY2021-FY2025
Trend
-2.0%
vs FY2024
Sector context
#83 of 211
Health Care
What the data says
At $6.53, Twist Bioscience Corp's tangible book value per share ranks #83 of 211 in the Health Care sector. Tangible Book Value per Share has declined for 3 consecutive years, from $13.06 in FY2022 to $6.53 in FY2025.
Based on SEC 10-K filings.
6.53 in FY2025 with a 5-year CAGR of -5.2%.
Declined from $9.45 to $6.53 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -20.6%
- 5-Year CAGR
- -5.2%
- 10-Year CAGR
- -
Sector benchmark
#83 of 211 in Health CareTop 39% of 211This company $6.53 Sector average $118.77
▼
-94.5% below sector average
Key checks
Key Insights
- Twist Bioscience Corp's tangible book value per share has declined for 3 consecutive years.
- In FY2025, tangible book value per share decreased 2.0% year-over-year.
- Ranks #83 out of 211 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.53 | -2.0% |
| FY2024 | $6.67 | -29.4% |
| FY2023 | $9.45 | -27.6% |
| FY2022 | $13.06 | +12.8% |
| FY2021 | $11.57 | +35.3% |
| FY2020 | $8.55 | +55.6% |
| FY2019 | $5.50 | +100.0% |
| FY2018 | -$72524.17 | -131728898.0% |
| FY2017 | -$0.06 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026